Chemfab Alkalis Ltd.

As of June 30, 2026, Chemfab Alkalis Ltd. carries a market capitalization of 5.31B, placing it among publicly traded companies globally. Its enterprise value stands at 5.31B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Chemfab Alkalis Ltd. has 14.37M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Chemfab Alkalis Ltd. trades at an EV/EBITDA multiple of 20.37 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.81 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 5.31B versus a market cap of 5.31B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 13.55M in revenue per employee across its workforce of 216.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Chemfab Alkalis Ltd. recorded an income tax benefit of -24.32M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -26.76M and -2.44M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Chemfab Alkalis Ltd.'s stock has declined approximately 44.53% over the past 52 weeks. The 50-day moving average sits at 353.63, while the 200-day moving average is 380.02.

Over the twelve months ended June 30, 2026, Chemfab Alkalis Ltd. generated 2.93B in revenue and converted that into -2.44M in net income, yielding earnings per share of -0.17. EBITDA reached 260.49M, while operating income came in at -37.60M.

Over the twelve months ended June 30, 2026, Chemfab Alkalis Ltd. posted a gross margin of 30.25, reflecting its pricing power and cost economics. The operating margin of -1.28 and net profit margin of -0.08 provide insight into operational efficiency.